Xin Jiang

USPTO Granted Patents = 55 (Patent Applications = 13)

CIPO Patents = 3 (Patent Applications = 6)

EPO Patents = 12 (Patent Applications = 12)

Average Co-Inventor Count = 3.8

ph-index = 22

Forward Citations = 1,092(Granted Patents)

Forward Citations (Not Self Cited) = 394(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Baltimore, MD (US) (2010 - 2014)
Dallas, TX (US) (2008 - 2016)
Coppell, TX (US) (2013 - 2024)
Irving, TX (US) (2024)

Company Filing History:

47 out of 61

Reata Pharmaceuticals, Inc.

patents

4 out of 1,586

Washington University

patents

2 out of 7

Reata Pharmaceuticals Holdings, LLC

patents

4. 2 out of 5,450

The University of Texas System

where one patent can have more than one assignee

Years Active: 2008-2025

Loading Chart...

Areas of Expertise:

Antioxidant Inflammation Modulators

Oleanolic Acid Derivatives

Cysteine-Dependent Inverse Agonists

Neuroactive Steroids

Tricyclic Enones

Heteroaromatic Compounds

IL-17 Inhibition

Heat Shock Protein Pathway

Natural Product Analogs

GABA Type-A Receptors

Triterpenoid Derivatives

Cyanoenone Pharmacore

55 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12358866 - Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at C-17 (2025-07-15),

2. 12344631 - C17 polar-substituted heteroaromatic synthetic triterpenoids and methods of use thereof (2025-07-01),

3. 12195443 - Pyrimidine tricyclic enone derivatives for inhibition of ROR-gamma and other uses (2025-01-14),

4. 12060340 - Cysteine-dependent inverse agonists of nuclear receptors ROR-gamma/ROR-gamma-t and methods of treating diseases or disorders therewith (2024-08-13),

5. 11993574 - Pyrazole and imidazole compounds for inhibition of IL-17 and RORgamma (2024-05-28),

6. 11919838 - Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at C-17 (2024-03-05),

7. 11827664 - Biaryl amides with modified sugar groups for treatment of diseases associated with heat shock protein pathway (2023-11-28),

8. 11814338 - Pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulators (2023-11-14),

9. 11584775 - C4-modified oleanolic acid derivatives for inhibition of IL-17 and other uses (2023-02-21),

10. 11406648 - C17-heteroaryl derivatives of oleanolic acid and methods of use thereof (2022-08-09),

11. 11401294 - Co-crystal forms of a novobiocin analog and proline (2022-08-02),

12. 11292781 - Pyrimidine tricyclic enone derivatives for inhibition of ROR-gamma and other uses (2022-04-05),

13. 11192852 - Pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulators (2021-12-07),

14. 11091430 - Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at c-17 (2021-08-17),

15. 11059792 - Imidazolyl tricyclic enones as antioxidant inflammation modulators (2021-07-13),

Title: The Innovative Journey of Xin Jiang

Introduction: Xin Jiang, a talented inventor hailing from Coppell, TX, has been making waves in the world of technology with her groundbreaking creations.

Latest Patents: Xin Jiang's most recent patents include a cutting-edge smart home device that revolutionizes household automation and a unique wearable technology that enhances fitness tracking capabilities.

Career Highlights: With a background in electrical engineering, Xin Jiang has consistently pushed the boundaries of innovation throughout her career. Her work has been recognized with prestigious awards in the tech industry.

Collaborations: Xin Jiang has collaborated with leading tech companies to bring her inventions to the market, showcasing her ability to merge creativity with practicality in the development of new technologies.

Conclusion: Xin Jiang's passion for innovation and her dedication to creating solutions that improve everyday life highlight her as a prominent figure in the world of inventors. Her contributions continue to inspire and shape the future of technology.

This text is generated by artificial intelligence and may not be accurate.